SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ. American Joint Committee on Cancer (AJCC). Manual for staging of cancer. 4th edition. Philadelphia: J. B. Lippincott, 1992.
  • 2
    Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumours. International Classification of Tumours. Geneva: World Health Organization, 1973: 199.
  • 3
    Jordan AM, Weingarten J, Murphy WM. Transitional cell neoplasms of the urinary bladder: can biological potential be predicted from histologic grading? Cancer 1987; 60:276674.
  • 4
    Schapers RFM, Pauwels RPE, Wijnen JThM, Arends JW, Thunissen FBJM, Coebergh JWW, et al. A simplified grading method of transitional cell carcinoma of the urinary bladder: reproducibility, clinical significance, and comparison with other prognostic parameters. Br J Urol 1993;73: 62531.
  • 5
    Vasko J, Malmström PU, Taube A, Wester K, Busch C. Toward an objective method of mitotic figure counting and its prognostic significance in bladder cancer. J Urol Pathol 1995; 3:31526.
  • 6
    Barnes DM, Gillett CE. Determination of cell proliferation. J Clin Pathol Mol Pathol 1995; 48:M2M5.
  • 7
    Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31:1320.
  • 8
    Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, et al. Immunobiochemical and molecular biologic characterisation of the cell proliferation–associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991; 138:86773.
  • 9
    Gerdes J, Lemke H, Baisch H, Wacher H-H, Schwab U, Stein H. Cell cycle analysis of a cell proliferation–associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133:17105.
  • 10
    Cattoretti G, Becker MGH, Key G, Duchrow M, Schlueter C, Galle J, et al. Monoclonal antibodies against recombinant parts of the K1-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1991; 168:35763.
  • 11
    Bush C, Price P, Parkins CS, Bailey MJ, Boyd J, Jones CR, et al. Proliferation in human bladder carcinoma measured by Ki-67 antibody labelling: its potential clinical importance. Br J Cancer 1991; 64:35760.
  • 12
    Okamura K, Miyake K, Koshikawa T, Asai J. Growth fractions of transitional cell carcinomas of the bladder defined by the monoclonal antibody Ki-67. J Urol 1990; 144:8758.
  • 13
    Limas C, Bigler A, Bair R, Bernhart P, Reddy P. Proliferative activity of urothelial neoplasms: comparison of BrdU incorporation, Ki67 expression, and nucleolar organiser regions. J Clin Pathol 1993; 46:15965.
  • 14
    Pauwels RPE, Schapers RFM, Smeets AWGB, Debruyne FMJ, Geraedts JPM. Grading of superficial bladder cancer. Br J Urol 1988; 61:12934.
  • 15
    Baak JPA, Oort J. Obtaining quantitative data. In: BaakJPA, OortJ. A manual of morphometry in diagnostic pathology. New York: Springer-Verlag, 1983:1820.
  • 16
    Malmström PU, Busch C, Norlén BJ. Recurrence, progression and survival in bladder cancer. Scand J Urol Nephrol 1987; 21:18595.
  • 17
    Popov Z, Hoznek A, Colombel M, Bastuji-Garin S, Lefrere-Belda M, Bellot J, et al. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder. Cancer 1997; 80:147281.
  • 18
    Asakura T, Takano Y, Iki M, Suwa Y, Noguchi S, Kubota Y, et al. Prognostic value of Ki-67 for recurrence and progression of superficial bladder cancer. J Urol 1997; 158:3858.
  • 19
    Smits G, Schaafsma E, Kiemeney L, Caris C, Debruyne F, Witjes JA. Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression. Urology 1998; 52:100914.
  • 20
    Blomjous CEM, Smeulders AWM, Baak JPA, Vos W, Van Galen EM, Meijer CJLM. A comparative study in morphometric grading of transitional cell carcinoma of the urinary bladder. Anal Quant Cytol Histol 1989;11: 42632.
  • 21
    Kruger S, Muller H. Correlation of morphometry, nucleolar organiser regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas. Br J Urol 1995; 75:4804.
  • 22
    Stavropoulos NE, Ioackim Velogianni E, Hastazeris K, Kitsiou E, Stefanaki S, Agnantis N. Growth fractions in bladder cancer defined by Ki67: association with cancer grade, category and recurrence rate of superficial lesions. Br J Urol 1993;72: 7369.
  • 23
    Suwa Y, Takano Y, Iki M, Asakura T, Noguchi S, Masuda M. Prognostic significance of Ki-67 expression in transitional cell bladder carcinoma after radical cystectomy. Pathol Res Pract 1997; 193:5516.
  • 24
    Briggs NC, Young TB, Gilchrist KW, Vaillancourt AM, Messing EM. Age as a predictor of an aggressive clinical course for superficial bladder cancer in men. Cancer 1992; 69:144551.